Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.

Saved in:
Bibliographic Details
Title: Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.
Authors: Moreno DA; Molecular Oncology Research Center Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., da Silva LS; Molecular Oncology Research Center Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Zanon MF; Molecular Diagnosis Laboratory Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Bonatelli M; Molecular Diagnosis Laboratory Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., de Paula FE; Molecular Diagnosis Laboratory Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., de Medeiros Matsushita M; Pathology Department Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Teixeira GR; Pathology Department Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Santana IVV; Pathology Department Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil., Saggioro F; Department of Pathology and Forensic Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Neder L; Department of Pathology and Forensic Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Stavale JN; Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Malheiros SMF; Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Lima M; AC Camargo Hospital, São Paulo, Brazil., Hajj GNM; AC Camargo Hospital, São Paulo, Brazil., Garcia-Rivello H; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Christiansen S; Pathology Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina., Nunes S; Pediatric Oncology Department, Hospital São João, Porto, Portugal., da Costa MJG; Pediatric Oncology Department, Hospital São João, Porto, Portugal., Soares MJ; Clinical Hematology Department, Hospital São João, Porto, Portugal., Pinheiro J; Department of Pathology, Hospital São João, Porto, Portugal., Junior CA; Pediatric Oncology Department, Pediatric Neurosurgery Department, Barretos Cancer Hospital, Barretos, Brazil., Mançano BM; Molecular Oncology Research Center Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil.; Pediatric Oncology Department, Pediatric Neurosurgery Department, Barretos Cancer Hospital, Barretos, Brazil., Reis RM; Molecular Oncology Research Center Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil. ruireis.hcb@gmail.com.; Molecular Diagnosis Laboratory Dr. Paulo Prata, Barretos Cancer Hospital, Barretos, Brazil. ruireis.hcb@gmail.com.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal. ruireis.hcb@gmail.com.; School of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal. ruireis.hcb@gmail.com.
Source: Journal of neuro-oncology [J Neurooncol] 2022 Mar; Vol. 157 (1), pp. 27-35. Date of Electronic Publication: 2022 Feb 15.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first